International Meeting “Immunotherapy of Cancer: Challenges and Needs” View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2007-04

AUTHORS

Maria Ferrantini, Imerio Capone, Francesco M. Marincola, Giorgio Parmiani, Filippo Belardelli

ABSTRACT

The main aims of the international meeting "Immunotherapy of Cancer: Challenges and Needs" were to review the state of the art of cancer immunotherapy and to identify critical issues which deserve special attention for promoting progress of research in this field, with a particular focus on the perspectives of clinical research. Novel concepts and strategies for identifying, monitoring and predicting effective responses to cancer immunotherapy protocols were presented, focused on the use of adjuvants (CpG oligonucleotides) or cytokines (IFN-alpha) to enhance the efficacy of cancer vaccines. Moreover, the possible advantages of using different types of dendritic cells (for active immunization strategies) or T cells (for adoptive immunotherapy protocols) were debated. A consensus was achieved on the need for enhancing the efficacy of cancer vaccines or adoptive cell immunotherapy by combining these strategies with other anti-cancer treatments, including chemotherapy. Finally, initiatives for promoting clinical research by establishing a strategic cooperation in the field of cancer immunotherapy based on the active participation of all the relevant actors, including public institutions responsible of Public Health, National Cancer Institutes, industry, representatives of regulatory bodies, and patients' organizations were proposed. More... »

PAGES

581-585

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00262-006-0251-6

DOI

http://dx.doi.org/10.1007/s00262-006-0251-6

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1034648291

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/17131119


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1107", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Immunology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Clinical Trials as Topic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Immunotherapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasms", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Istituto Superiore di Sanit\u00e0", 
          "id": "https://www.grid.ac/institutes/grid.416651.1", 
          "name": [
            "Department of Cell Biology and Neurosciences, Istituto Superiore di Sanit\u00e0, Viale Regina Elena 299, 00161, Rome, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ferrantini", 
        "givenName": "Maria", 
        "id": "sg:person.01272007632.86", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01272007632.86"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Istituto Superiore di Sanit\u00e0", 
          "id": "https://www.grid.ac/institutes/grid.416651.1", 
          "name": [
            "Department of Cell Biology and Neurosciences, Istituto Superiore di Sanit\u00e0, Viale Regina Elena 299, 00161, Rome, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Capone", 
        "givenName": "Imerio", 
        "id": "sg:person.01330005620.36", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01330005620.36"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "National Institutes of Health Clinical Center", 
          "id": "https://www.grid.ac/institutes/grid.410305.3", 
          "name": [
            "Immunogenetics Section, Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Marincola", 
        "givenName": "Francesco M.", 
        "id": "sg:person.014223631617.46", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014223631617.46"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Istituto Nazionale dei Tumori", 
          "id": "https://www.grid.ac/institutes/grid.417893.0", 
          "name": [
            "Department of Experimental Oncology, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Parmiani", 
        "givenName": "Giorgio", 
        "id": "sg:person.0700363627.04", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0700363627.04"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Istituto Superiore di Sanit\u00e0", 
          "id": "https://www.grid.ac/institutes/grid.416651.1", 
          "name": [
            "Department of Cell Biology and Neurosciences, Istituto Superiore di Sanit\u00e0, Viale Regina Elena 299, 00161, Rome, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Belardelli", 
        "givenName": "Filippo", 
        "id": "sg:person.077031223.43", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.077031223.43"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/nri1668", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008071573", 
          "https://doi.org/10.1038/nri1668"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nri1668", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008071573", 
          "https://doi.org/10.1038/nri1668"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nm1381", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014747906", 
          "https://doi.org/10.1038/nm1381"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nm1381", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014747906", 
          "https://doi.org/10.1038/nm1381"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nm1356", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016783900", 
          "https://doi.org/10.1038/nm1356"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nm1356", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016783900", 
          "https://doi.org/10.1038/nm1356"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa053007", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027682287"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/jcb.20953", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032734655"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/0008-5472.can-05-3396", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036929088"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdj138", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046118800"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.4049/jimmunol.176.12.7726", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1077250169"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.4049/jimmunol.177.2.1338", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1077264465"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2007-04", 
    "datePublishedReg": "2007-04-01", 
    "description": "The main aims of the international meeting \"Immunotherapy of Cancer: Challenges and Needs\" were to review the state of the art of cancer immunotherapy and to identify critical issues which deserve special attention for promoting progress of research in this field, with a particular focus on the perspectives of clinical research. Novel concepts and strategies for identifying, monitoring and predicting effective responses to cancer immunotherapy protocols were presented, focused on the use of adjuvants (CpG oligonucleotides) or cytokines (IFN-alpha) to enhance the efficacy of cancer vaccines. Moreover, the possible advantages of using different types of dendritic cells (for active immunization strategies) or T cells (for adoptive immunotherapy protocols) were debated. A consensus was achieved on the need for enhancing the efficacy of cancer vaccines or adoptive cell immunotherapy by combining these strategies with other anti-cancer treatments, including chemotherapy. Finally, initiatives for promoting clinical research by establishing a strategic cooperation in the field of cancer immunotherapy based on the active participation of all the relevant actors, including public institutions responsible of Public Health, National Cancer Institutes, industry, representatives of regulatory bodies, and patients' organizations were proposed.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s00262-006-0251-6", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.2712967", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.4055141", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1096240", 
        "issn": [
          "0340-7004", 
          "1432-0851"
        ], 
        "name": "Cancer Immunology, Immunotherapy", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "4", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "56"
      }
    ], 
    "name": "International Meeting \u201cImmunotherapy of Cancer: Challenges and Needs\u201d", 
    "pagination": "581-585", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "a50d351d29e2d1b39ec7339ce7574dcfe7bb14598a800f5cbc8325d8b9c48d9f"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "17131119"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "8605732"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00262-006-0251-6"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1034648291"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00262-006-0251-6", 
      "https://app.dimensions.ai/details/publication/pub.1034648291"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T14:32", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000373_0000000373/records_13102_00000001.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007%2Fs00262-006-0251-6"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00262-006-0251-6'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00262-006-0251-6'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00262-006-0251-6'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00262-006-0251-6'


 

This table displays all metadata directly associated to this object as RDF triples.

157 TRIPLES      21 PREDICATES      43 URIs      26 LITERALS      14 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00262-006-0251-6 schema:about N0d301caca4f44139beb32a216c65b148
2 N42fab79617994807845ebb17cca29b99
3 N4c5b92e17c3a4ffc8b4486dd1a4255d2
4 N822ca2a9eb754d7989e3c2d5de4784ff
5 Na1e80071d292498485b8c6a466b94993
6 anzsrc-for:11
7 anzsrc-for:1107
8 schema:author N88170abbe61e47cfa8dd09b9d8894cdc
9 schema:citation sg:pub.10.1038/nm1356
10 sg:pub.10.1038/nm1381
11 sg:pub.10.1038/nri1668
12 https://doi.org/10.1002/jcb.20953
13 https://doi.org/10.1056/nejmoa053007
14 https://doi.org/10.1093/annonc/mdj138
15 https://doi.org/10.1158/0008-5472.can-05-3396
16 https://doi.org/10.4049/jimmunol.176.12.7726
17 https://doi.org/10.4049/jimmunol.177.2.1338
18 schema:datePublished 2007-04
19 schema:datePublishedReg 2007-04-01
20 schema:description The main aims of the international meeting "Immunotherapy of Cancer: Challenges and Needs" were to review the state of the art of cancer immunotherapy and to identify critical issues which deserve special attention for promoting progress of research in this field, with a particular focus on the perspectives of clinical research. Novel concepts and strategies for identifying, monitoring and predicting effective responses to cancer immunotherapy protocols were presented, focused on the use of adjuvants (CpG oligonucleotides) or cytokines (IFN-alpha) to enhance the efficacy of cancer vaccines. Moreover, the possible advantages of using different types of dendritic cells (for active immunization strategies) or T cells (for adoptive immunotherapy protocols) were debated. A consensus was achieved on the need for enhancing the efficacy of cancer vaccines or adoptive cell immunotherapy by combining these strategies with other anti-cancer treatments, including chemotherapy. Finally, initiatives for promoting clinical research by establishing a strategic cooperation in the field of cancer immunotherapy based on the active participation of all the relevant actors, including public institutions responsible of Public Health, National Cancer Institutes, industry, representatives of regulatory bodies, and patients' organizations were proposed.
21 schema:genre research_article
22 schema:inLanguage en
23 schema:isAccessibleForFree false
24 schema:isPartOf N0fa7d0452eee45b58f0d9d44cd2c864b
25 Neae5850254d94f5a9151c876eabf2e4a
26 sg:journal.1096240
27 schema:name International Meeting “Immunotherapy of Cancer: Challenges and Needs”
28 schema:pagination 581-585
29 schema:productId N0c1795f991d241c6879c87e3b2be9cc8
30 N71046ed879e949489252b9c8440281f1
31 N854491a957604e7fad83408568715bdb
32 N985ed665c56b40bd97d895f8dd22306c
33 Nec2ff5b7db9742cbb9aa5ea933446c33
34 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034648291
35 https://doi.org/10.1007/s00262-006-0251-6
36 schema:sdDatePublished 2019-04-11T14:32
37 schema:sdLicense https://scigraph.springernature.com/explorer/license/
38 schema:sdPublisher N42f6f85534f6435390c60a4dfe7f73f9
39 schema:url http://link.springer.com/10.1007%2Fs00262-006-0251-6
40 sgo:license sg:explorer/license/
41 sgo:sdDataset articles
42 rdf:type schema:ScholarlyArticle
43 N0c1795f991d241c6879c87e3b2be9cc8 schema:name dimensions_id
44 schema:value pub.1034648291
45 rdf:type schema:PropertyValue
46 N0d301caca4f44139beb32a216c65b148 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
47 schema:name Animals
48 rdf:type schema:DefinedTerm
49 N0fa7d0452eee45b58f0d9d44cd2c864b schema:volumeNumber 56
50 rdf:type schema:PublicationVolume
51 N403c122d83bd4fa481f58815866d7905 rdf:first sg:person.014223631617.46
52 rdf:rest N984101bc208f4a5f8ef909acca39aa7c
53 N42f6f85534f6435390c60a4dfe7f73f9 schema:name Springer Nature - SN SciGraph project
54 rdf:type schema:Organization
55 N42fab79617994807845ebb17cca29b99 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
56 schema:name Immunotherapy
57 rdf:type schema:DefinedTerm
58 N4c5b92e17c3a4ffc8b4486dd1a4255d2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
59 schema:name Humans
60 rdf:type schema:DefinedTerm
61 N64f7dca5a6fa46febe2341a2b3ec5ec6 rdf:first sg:person.077031223.43
62 rdf:rest rdf:nil
63 N6f0c2c38a072420a92a3dcb6d6cfacee rdf:first sg:person.01330005620.36
64 rdf:rest N403c122d83bd4fa481f58815866d7905
65 N71046ed879e949489252b9c8440281f1 schema:name readcube_id
66 schema:value a50d351d29e2d1b39ec7339ce7574dcfe7bb14598a800f5cbc8325d8b9c48d9f
67 rdf:type schema:PropertyValue
68 N822ca2a9eb754d7989e3c2d5de4784ff schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
69 schema:name Neoplasms
70 rdf:type schema:DefinedTerm
71 N854491a957604e7fad83408568715bdb schema:name pubmed_id
72 schema:value 17131119
73 rdf:type schema:PropertyValue
74 N88170abbe61e47cfa8dd09b9d8894cdc rdf:first sg:person.01272007632.86
75 rdf:rest N6f0c2c38a072420a92a3dcb6d6cfacee
76 N984101bc208f4a5f8ef909acca39aa7c rdf:first sg:person.0700363627.04
77 rdf:rest N64f7dca5a6fa46febe2341a2b3ec5ec6
78 N985ed665c56b40bd97d895f8dd22306c schema:name doi
79 schema:value 10.1007/s00262-006-0251-6
80 rdf:type schema:PropertyValue
81 Na1e80071d292498485b8c6a466b94993 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
82 schema:name Clinical Trials as Topic
83 rdf:type schema:DefinedTerm
84 Neae5850254d94f5a9151c876eabf2e4a schema:issueNumber 4
85 rdf:type schema:PublicationIssue
86 Nec2ff5b7db9742cbb9aa5ea933446c33 schema:name nlm_unique_id
87 schema:value 8605732
88 rdf:type schema:PropertyValue
89 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
90 schema:name Medical and Health Sciences
91 rdf:type schema:DefinedTerm
92 anzsrc-for:1107 schema:inDefinedTermSet anzsrc-for:
93 schema:name Immunology
94 rdf:type schema:DefinedTerm
95 sg:grant.2712967 http://pending.schema.org/fundedItem sg:pub.10.1007/s00262-006-0251-6
96 rdf:type schema:MonetaryGrant
97 sg:grant.4055141 http://pending.schema.org/fundedItem sg:pub.10.1007/s00262-006-0251-6
98 rdf:type schema:MonetaryGrant
99 sg:journal.1096240 schema:issn 0340-7004
100 1432-0851
101 schema:name Cancer Immunology, Immunotherapy
102 rdf:type schema:Periodical
103 sg:person.01272007632.86 schema:affiliation https://www.grid.ac/institutes/grid.416651.1
104 schema:familyName Ferrantini
105 schema:givenName Maria
106 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01272007632.86
107 rdf:type schema:Person
108 sg:person.01330005620.36 schema:affiliation https://www.grid.ac/institutes/grid.416651.1
109 schema:familyName Capone
110 schema:givenName Imerio
111 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01330005620.36
112 rdf:type schema:Person
113 sg:person.014223631617.46 schema:affiliation https://www.grid.ac/institutes/grid.410305.3
114 schema:familyName Marincola
115 schema:givenName Francesco M.
116 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014223631617.46
117 rdf:type schema:Person
118 sg:person.0700363627.04 schema:affiliation https://www.grid.ac/institutes/grid.417893.0
119 schema:familyName Parmiani
120 schema:givenName Giorgio
121 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0700363627.04
122 rdf:type schema:Person
123 sg:person.077031223.43 schema:affiliation https://www.grid.ac/institutes/grid.416651.1
124 schema:familyName Belardelli
125 schema:givenName Filippo
126 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.077031223.43
127 rdf:type schema:Person
128 sg:pub.10.1038/nm1356 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016783900
129 https://doi.org/10.1038/nm1356
130 rdf:type schema:CreativeWork
131 sg:pub.10.1038/nm1381 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014747906
132 https://doi.org/10.1038/nm1381
133 rdf:type schema:CreativeWork
134 sg:pub.10.1038/nri1668 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008071573
135 https://doi.org/10.1038/nri1668
136 rdf:type schema:CreativeWork
137 https://doi.org/10.1002/jcb.20953 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032734655
138 rdf:type schema:CreativeWork
139 https://doi.org/10.1056/nejmoa053007 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027682287
140 rdf:type schema:CreativeWork
141 https://doi.org/10.1093/annonc/mdj138 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046118800
142 rdf:type schema:CreativeWork
143 https://doi.org/10.1158/0008-5472.can-05-3396 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036929088
144 rdf:type schema:CreativeWork
145 https://doi.org/10.4049/jimmunol.176.12.7726 schema:sameAs https://app.dimensions.ai/details/publication/pub.1077250169
146 rdf:type schema:CreativeWork
147 https://doi.org/10.4049/jimmunol.177.2.1338 schema:sameAs https://app.dimensions.ai/details/publication/pub.1077264465
148 rdf:type schema:CreativeWork
149 https://www.grid.ac/institutes/grid.410305.3 schema:alternateName National Institutes of Health Clinical Center
150 schema:name Immunogenetics Section, Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, USA
151 rdf:type schema:Organization
152 https://www.grid.ac/institutes/grid.416651.1 schema:alternateName Istituto Superiore di Sanità
153 schema:name Department of Cell Biology and Neurosciences, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161, Rome, Italy
154 rdf:type schema:Organization
155 https://www.grid.ac/institutes/grid.417893.0 schema:alternateName Istituto Nazionale dei Tumori
156 schema:name Department of Experimental Oncology, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy
157 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...